Personalized neurorehabilitative precision medicine: from data to therapies 
(MWKNeuroReha) - a multi-centre prospective observational clinical trial to 
predict long-term outcome of patients with acute motor stroke

Blum, C; Baur, D; Achauer, L-C; Berens, P; Biergans, S; Erb, M; Hömberg, V; Huang, Z; Kohlbacher, O; Liepert, J; Lindig, T; Lohmann, G; Macke, JH; Römhild, J; Rösinger-Hein, C; Zrenner, B; Ziemann, U

doi:10.1186/s12883-022-02759-2

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Personalized neurorehabilitative precision medicine: from data to therapies (MWKNeuroReha) - a multi-centre prospective observational clinical trial to predict long-term outcome of patients with acute motor stroke

MPS-Authors

/persons/resource/persons84898

Erb, M
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons133483

Lohmann, G
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-022-02759-2.pdf
(出版社版)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Blum, C., Baur, D., Achauer, L.-C., Berens, P., Biergans, S., Erb, M., Hömberg, V., Huang, Z., Kohlbacher, O., Liepert, J., Lindig, T., Lohmann, G., Macke, J., Römhild, J., Rösinger-Hein, C., Zrenner, B., & Ziemann, U. (2022). Personalized neurorehabilitative precision medicine: from data to therapies (MWKNeuroReha) - a multi-centre prospective observational clinical trial to predict long-term outcome of patients with acute motor stroke. BMC Neurology, 22(1):. doi:10.1186/s12883-022-02759-2.

引用: https://hdl.handle.net/21.11116/0000-000A-A9C4-A

要旨

Background: Stroke is one of the most frequent diseases, and half of the stroke survivors are left with permanent impairment. Prediction of individual outcome is still difficult. Many but not all patients with stroke improve by approximately 1.7 times the initial impairment, that has been termed proportional recovery rule. The present study aims at identifying factors predicting motor outcome after stroke more accurately than before, and observe associations of rehabilitation treatment with outcome.
Methods: The study is designed as a multi-centre prospective clinical observational trial. An extensive primary data set of clinical, neuroimaging, electrophysiological, and laboratory data will be collected within 96 h of stroke onset from patients with relevant upper extremity deficit, as indexed by a Fugl-Meyer-Upper Extremity (FM-UE) score ≤ 50. At least 200 patients will be recruited. Clinical scores will include the FM-UE score (range 0-66, unimpaired function is indicated by a score of 66), Action Research Arm Test, modified Rankin Scale, Barthel Index and Stroke-Specific Quality of Life Scale. Follow-up clinical scores and applied types and amount of rehabilitation treatment will be documented in the rehabilitation hospitals. Final follow-up clinical scoring will be performed 90 days after the stroke event. The primary endpoint is the change in FM-UE defined as 90 days FM-UE minus initial FM-UE, divided by initial FM-UE impairment. Changes in the other clinical scores serve as secondary endpoints. Machine learning methods will be employed to analyze the data and predict primary and secondary endpoints based on the primary data set and the different rehabilitation treatments.
Discussion: If successful, outcome and relation to rehabilitation treatment in patients with acute motor stroke will be predictable more reliably than currently possible, leading to personalized neurorehabilitation. An important regulatory aspect of this trial is the first-time implementation of systematic patient data transfer between emergency and rehabilitation hospitals, which are divided institutions in Germany.